CLYM
Price
$1.98
Change
+$0.06 (+3.12%)
Updated
Dec 24 closing price
69 days until earnings call
SCPH
Price
$3.38
Change
-$0.04 (-1.17%)
Updated
Dec 24 closing price
84 days until earnings call
Ad is loading...

CLYM vs SCPH

Header iconCLYM vs SCPH Comparison
Open Charts CLYM vs SCPHBanner chart's image
Climb Bio
Price$1.98
Change+$0.06 (+3.12%)
Volume$402.54K
CapitalizationN/A
scPharmaceuticals
Price$3.38
Change-$0.04 (-1.17%)
Volume$78.89K
CapitalizationN/A
CLYM vs SCPH Comparison Chart
Loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLYM vs. SCPH commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Hold and SCPH is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (CLYM: $1.98 vs. SCPH: $3.38)
Brand notoriety: CLYM and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 131% vs. SCPH: 16%
Market capitalization -- CLYM: $133.1M vs. SCPH: $169.14M
CLYM [@Biotechnology] is valued at $133.1M. SCPH’s [@Biotechnology] market capitalization is $169.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 1 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • CLYM’s FA Score: 1 green, 4 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, CLYM is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 4 TA indicator(s) are bullish while SCPH’s TA Score has 4 bullish TA indicator(s).

  • CLYM’s TA Score: 4 bullish, 4 bearish.
  • SCPH’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than CLYM.

Price Growth

CLYM (@Biotechnology) experienced а -15.38% price change this week, while SCPH (@Biotechnology) price change was +4.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

CLYM is expected to report earnings on Mar 04, 2025.

SCPH is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCPH($169M) has a higher market cap than CLYM($133M). CLYM YTD gains are higher at: -26.667 vs. SCPH (-46.093). CLYM has higher annual earnings (EBITDA): -24.57M vs. SCPH (-71.31M). CLYM has more cash in the bank: 193M vs. SCPH (91.5M). CLYM has less debt than SCPH: CLYM (58K) vs SCPH (52.5M). SCPH has higher revenues than CLYM: SCPH (30.3M) vs CLYM (0).
CLYMSCPHCLYM / SCPH
Capitalization133M169M79%
EBITDA-24.57M-71.31M34%
Gain YTD-26.667-46.09358%
P/E RatioN/AN/A-
Revenue030.3M-
Total Cash193M91.5M211%
Total Debt58K52.5M0%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLYMSCPH
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 5 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRTTX515.585.53
+1.08%
Vanguard Russell 3000 Index I
MLOZX8.370.07
+0.84%
Cohen & Steers Future of Energy Z
VDMRX8.620.01
+0.12%
Virtus KAR Developing Markets R6
PXNIX10.220.01
+0.10%
Impax International Sust Econ Instl
GILLX22.77N/A
N/A
Goldman Sachs Enh Core EqFund-Instl

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with RLYB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
+3.13%
RLYB - CLYM
41%
Loosely correlated
-5.95%
VERU - CLYM
31%
Poorly correlated
-2.87%
CMRX - CLYM
28%
Poorly correlated
+10.60%
ANAB - CLYM
28%
Poorly correlated
-0.57%
SCPH - CLYM
27%
Poorly correlated
-1.17%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
-1.17%
MGTX - SCPH
44%
Loosely correlated
+1.31%
BEAM - SCPH
43%
Loosely correlated
+0.38%
ABCL - SCPH
43%
Loosely correlated
+1.03%
CDXS - SCPH
43%
Loosely correlated
+1.42%
PLRX - SCPH
43%
Loosely correlated
+1.12%
More